The fact that DARC belongs to a family of seven transmembrane domain proteins and that almost 40% of all marketed medicines interact with this class of proteins strongly suggests that DARC is an excellent target for successfully developing therapeutics to treat malaria. Here, ACKR1 is linked to malaria.